Tags: Menopause | Osteoporosis | duavee | menopause | drug | hot | flash

FDA OKs Drug That Reduces Hot Flashes With Fewer Side Effects

Thursday, 03 Oct 2013 04:31 PM

U.S. health regulators approved Pfizer Inc's menopause drug Duavee, which the company hopes will reduce hot flashes with fewer side effects than older hormone-replacement therapies.

The Food and Drug Administration said on Thursday it approved the drug to treat women with moderate to severe menopause symptoms and to prevent post-menopausal osteoporosis, a bone disease which can increase the risk of fractures.

The drug, which Pfizer is developing with Ligand Pharmaceuticals Inc, combines bazedoxifene - which belongs to a class of drugs known as selective estrogen receptor modulators, or SERMS - and conjugated estrogens, which are derived from the urine of pregnant horses and contained in Pfizer's menopause drug Premarin.

© 2015 Thomson/Reuters. All rights reserved.

1Like our page
2Share
Health-News
U.S. health regulators approved Pfizer Inc's menopause drug Duavee,which the company hopes will reduce hot flashes with fewer side effects than older hormone-replacement therapies. The Food and Drug Administration said on Thursday it approved the drug to treat women...
duavee,menopause,drug,hot,flash,pfizer
109
2013-31-03
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved